| HOME >> BIOLOGY >> TECHNOLOGY |
IRVINE, Calif., April 3, 2008 /PRNewswire/ -- Quest International, Inc. (Quest) announced they will show true 12-bit, grayscale mammographic images, utilizing an Apple Mac system, OsiriX and the Totoku, ME551i2, medical LCD display, at the upcoming Society for Imaging Informatics in Medicine (SIIM), to be held in Seattle, Washington.
Quest will be demonstrating the imaging breakthrough using the Apple Mac Pro 8-Core workstation with two ME551i2 medical, LCD displays. The ME551i2 is a 21.3-inch, 5 megapixel, DICOM-compliant diagnostic display. The ME551i2 is the only display able to interface with the new 64-bit version of OsiriX, the most advanced open-source PACS workstation DICOM viewer on the market.
The project began in early 2007 when Quest was asked about displays that could be used with Mac systems for the medical market. Immediately, Quest's research and development team, lead by Medical Imaging Product Manager, Herb Berkwits, began researching the hardware and software requirements. "Our team learned that with some software changes, the ME551i2 would be able to display a true 12-bit image," commented Berkwits. Upon being notified by their integrators of Quest's discovery, Apple approached the Irvine, California based company with the idea of working together to develop a software solution. Quest International's Vice President Kaye Katouzian said, "Apple approached us with interest in the project. They were looking for display solutions, and we were happy to cooperate by supplying the ME551i2 displays they required." "Because of our commitment to excellence in medical imaging, we were very excited to be involved with the project," continued Katouzian.
In an effort to minimize any delays, Apple suggested that the OsiriX
software development team get involved. "Quest is pleased to be working
with the European OsiriX developers, providing technical assistance and
support, our expertise in both software and hardware engineering inspir
'/>"/>
| SOURCE Quest International, Inc. Copyright©2008 PR Newswire. All rights reserved |